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Role of the Pvr signaling Pathway in a Fly Model for Myotonic Dystrophy Type 1
Maya Takashima, Huda Al-Bana, Grace Holcomb, Dr. Ginny Morriss
University of Mary Washington
Myotonic Dystrophy Type 1 (DM1) is a multi-systemic genetic disorder that 
causes severe muscle weakening and wasting. This phenotype is the result 
of the expansion of CTG repeats at the 3’ untranslated region in the DMPK
gene1. 50-3000 repeats are present in DM1 patients.
• To determine which downstream gene targets and Drosophila fly lines 
and stocks to utilize in mating schemes.
• To use a fly model to understand the role of the pvr signaling pathway 
in muscle wasting due to DM1 and determine which downstream 
pathway, PI3K/Akt and/or Ras/Mek/Erk is primarily affected.
Mating schemes were planned by 
working backwards 
1. Determined desired genotype 
of progeny 
2. Used stock fly genotypes to 
produce desired progeny 
UAS-CTG250 [Insert Stock]
“Promoter”- Gal4
“Promoter”- Gal4 ; UAS-CTG250 ; [Insert Stock]
UAS-CTG250 ; [Insert Stock]
Want:
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• To look at specific phenotypes that are characteristic of DM1, such as 
splicing and nuclear foci defects. 
• To look at the molecular and physiological change due to modulation, 
flight tests will be conducted. 
• Perform histological tests to look at the change in muscle architecture 
that is produced by the in vivo modulation. 
To look at the phenotypic changes that occur due to the CTG expansion, a 
Drosophila model was utilized. The Drosophila equivalent to the PDGFRβ 
pathway is the pvr pathway.
Methods (cont.)
Flybase is a database for Drosophila genes 
and genomes – it was utilized to determine 
the desired fly lines and stocks.
Flybase provides a link to Bloomington
Stock Center, which offers more details on 
the stock and fly line, such as chromosomal 
location.• The platelet-derived growth factor receptor β (PDGFRβ) is involved in 
cell growth, survival, and skeletal muscle hypertrophy2. 
• PDGFRβ deregulation has been shown to be implicated in Duchenne 
Muscular Dystrophy3. 
• A previous study showed that PDGFRβ activation was significantly 
reduced DM14. 
• With the involvement in cell growth, survival, and skeletal muscle 
hypertrophy, then the pathway’s deregulation could contribute to the 
muscle wasting and weakening seen in DM1. 
• The PDFGRβ signaling pathway signals through two downstream 
pathways: PI3K/Akt and Ras/Mek/Erk pathway. To activate these two 
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